GALT - Galectin Therapeutics - Stock Forecast

Coverage Performance Price Targets & Ratings Chart Insider Trading

GALT is currently covered by 1 analysts with an average price target of $7.38. This is a potential upside of $4.97 (206.22%) from yesterday's end of day stock price of $2.41.

Galectin Therapeutics's activity chart (see below) currently has 6 price targets and 7 ratings on display. The stock rating distribution of GALT is 100% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 73.33% with an average time for these price targets to be met of 135.67 days.

Highest price target for GALT is $2, Lowest price target is $1, average price target is $7.38.

Most recent stock forecast was given by ED ARCE from HC WAINWRIGHT on 15-Aug-2023. First documented stock forecast 28-Mar-2016.

Best performing analysts who are covering GALT - Galectin Therapeutics:

Yasmeen Rahimi Vernon Bernardino Ed Arce

Currently out of the existing stock ratings of GALT, 3 are a BUY (100%).

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

11

7 months 14 days ago

1/5 (20%)

$8.6 (358.33%)

168

Buy

8

$6.29 (367.84%)

3

6 years 2 months 25 days ago

3/3 (100%)

$3.74 (87.79%)

140

Buy

5

$3.29 (192.40%)

2

6 years 5 months 23 days ago

3/3 (100%)

$2.56 (104.92%)

99

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is GALT (Galectin Therapeutics) average time for price targets to be met?

On average it took 135.67 days on average for the stock forecasts to be realized with a an average price target met ratio 73.33

Which analyst has the current highest performing score on GALT (Galectin Therapeutics) with a proven track record?

YASMEEN RAHIMI

Which analyst has the current lower performing score on GALT (Galectin Therapeutics) with a proven track record?

ED ARCE

Which analyst has the most public recommendations on GALT (Galectin Therapeutics)?

Yasmeen Rahimi works at PIPER SANDLER and has 4 price targets and 4 ratings on GALT

Which analyst is the currently most bullish on GALT (Galectin Therapeutics)?

Yasmeen Rahimi with highest potential upside - $6.29

Which analyst is the currently most reserved on GALT (Galectin Therapeutics)?

Ed Arce with lowest potential downside - -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?